Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty

Part of paid clinical trials in Miami, Florida.

Sponsor
University of Miami
Study ID
NCT06902285
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Magnesium Threonate — DRUG
    Participants will receive a daily 145 mg pill by mouth 30 minutes before going to sleep
  • Control — OTHER
    Participants will receive two sugar pills daily by mouth 30 minutes before going to sleep

Study Details

The study team is conducting a study to see if Magnesium-L-Threonate (MgT) can help improve how well participants sleep and reduce pain after total joint replacement surgery

Key Dates

Start date
Apr 21, 2025
Status verified
Apr 2026
Primary completion
Jul 1, 2026
Completion
Jul 1, 2026

Study Design

Enrollment
64 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Magnesium L Threonate Group
    Participants in this group will receive the Magnesium L Threonate intervention for up to 6 weeks postoperatively
  • Placebo Comparator: Control Group
    Participants in this group will receive the placebo comparator for up to 6 weeks postoperatively

Primary Outcome Measure

Change in Epsworth Sleepiness Score [ Time Frame: 2 weeks, 4 weeks, 6 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Miami HospitalMiamiFlorida33136
Natalia Cruz, MD
Jonathan Stern, MD (SUB_INVESTIGATOR)
Natalia Cruz, MD (SUB_INVESTIGATOR)
Victor H Hernandez, MD (PRINCIPAL_INVESTIGATOR)
Colin McNamara, MD (SUB_INVESTIGATOR)

Find similar trials in Miami, FL

By condition
Osteoarthritis (other)
By specialty
OrthopedicsMusculoskeletal disorders
By research site
University of Miami Hospital· Miami, FL

Related Studies